Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer.
暂无分享,去创建一个
A. Ribas | D. Noe | J. Gómez-Navarro | D. C. Hanson | Amarnath Sharma | S. Bernstein | P. Canniff | R. Millham | D. Guyot